Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 483

1.

Visual dysfunction of the superior colliculus in de novo Parkinsonian patients.

Moro E, Bellot E, Meoni S, Pelissier P, Hera R, Dojat M, Coizet V; Superior Colliculus Study Group.

Ann Neurol. 2020 Feb 6. doi: 10.1002/ana.25696. [Epub ahead of print]

PMID:
32030799
2.

Sex differences in movement disorders.

Meoni S, Macerollo A, Moro E.

Nat Rev Neurol. 2020 Feb;16(2):84-96. doi: 10.1038/s41582-019-0294-x. Epub 2020 Jan 3. Review.

PMID:
31900464
3.

A transcriptional and post-transcriptional dysregulation of Dishevelled 1 and 2 underlies the Wnt signaling impairment in type I Gaucher disease experimental models.

Costa R, Bellesso S, Lualdi S, Manzoli R, Pistorio V, Filocamo M, Moro E.

Hum Mol Genet. 2020 Jan 15;29(2):274-285. doi: 10.1093/hmg/ddz293.

PMID:
31816052
4.

A Case of Peripherally Induced Task-Specific "Lipstick Dystonic Tremor".

Cavallieri F, Valzania F, Vercueil L, Moro E, Fraix V.

Tremor Other Hyperkinet Mov (N Y). 2019 Oct 1;9. doi: 10.7916/tohm.v0.689. eCollection 2019.

5.

The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.

Moro E, Degli Esposti E, Borghese G, Manzara F, Zanello M, Raimondo D, Gava G, Arena A, Casadio P, Meriggiola MC, Seracchioli R.

Medicina (Kaunas). 2019 Aug 30;55(9). pii: E549. doi: 10.3390/medicina55090549. Review.

6.

How to Hide One's Relationships from Link Prediction Algorithms.

Waniek M, Zhou K, Vorobeychik Y, Moro E, Michalak TP, Rahwan T.

Sci Rep. 2019 Aug 21;9(1):12208. doi: 10.1038/s41598-019-48583-6.

7.

Impaired Mitochondrial ATP Production Downregulates Wnt Signaling via ER Stress Induction.

Costa R, Peruzzo R, Bachmann M, Montà GD, Vicario M, Santinon G, Mattarei A, Moro E, Quintana-Cabrera R, Scorrano L, Zeviani M, Vallese F, Zoratti M, Paradisi C, Argenton F, Brini M, Calì T, Dupont S, Szabò I, Leanza L.

Cell Rep. 2019 Aug 20;28(8):1949-1960.e6. doi: 10.1016/j.celrep.2019.07.050.

8.

First Impressions Can Be Deceiving: Surgical Outcomes of Laparoscopic Myomectomy in Patients Pretreated with Ulipristal Acetate.

Frascà C, Arena A, Degli Esposti E, Raimondo D, Del Forno S, Moro E, Zanello M, Mabrouk M, Seracchioli R.

J Minim Invasive Gynecol. 2019 Aug 13. pii: S1553-4650(19)30373-5. doi: 10.1016/j.jmig.2019.04.026. [Epub ahead of print]

PMID:
31419494
9.

Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature.

Zanello M, Borghese G, Manzara F, Degli Esposti E, Moro E, Raimondo D, Abdullahi LO, Arena A, Terzano P, Meriggiola MC, Seracchioli R.

Medicina (Kaunas). 2019 Aug 14;55(8). pii: E477. doi: 10.3390/medicina55080477. Review.

10.

Deep Infiltrating Endometriosis and Spontaneous Hemoperitoneum: A Life-Threatening Situation Treated by Laparoscopy.

Mabrouk M, Arena A, Moro E, Raimondo D, Seracchioli R.

J Minim Invasive Gynecol. 2019 Jul 31. pii: S1553-4650(19)30324-3. doi: 10.1016/j.jmig.2019.07.020. [Epub ahead of print]

PMID:
31376586
11.

Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders.

Baj A, Bistoletti M, Bosi A, Moro E, Giaroni C, Crema F.

Toxins (Basel). 2019 Jul 31;11(8). pii: E449. doi: 10.3390/toxins11080449. Review.

12.

Acute lethargy after abrupt apomorphine withdrawal in Parkinson's disease.

Cavallieri F, Fraix V, Meoni S, Krack P, Moro E, Castrioto A.

J Neurol Sci. 2019 Sep 15;404:44-46. doi: 10.1016/j.jns.2019.07.011. Epub 2019 Jul 10. No abstract available.

PMID:
31325667
13.

Neuromodulation for children with cerebral palsy.

Meoni S, Moro E.

Dev Med Child Neurol. 2020 Jan;62(1):6. doi: 10.1111/dmcn.14311. Epub 2019 Jul 4. No abstract available.

PMID:
31273761
14.

Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.

Giannini G, Francois M, Lhommée E, Polosan M, Schmitt E, Fraix V, Castrioto A, Ardouin C, Bichon A, Pollak P, Benabid AL, Seigneuret E, Chabardes S, Wack M, Krack P, Moro E.

Neurology. 2019 Jul 2;93(1):e97-e105. doi: 10.1212/WNL.0000000000007665. Epub 2019 May 17.

PMID:
31101738
15.

Highlights of the XXIII World Congress on Parkinson's Disease and Related Disorders.

Moro E, Fernandez HH.

Parkinsonism Relat Disord. 2019 Feb;59:1. doi: 10.1016/j.parkreldis.2019.03.011. No abstract available.

PMID:
31029231
16.

Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis.

Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C.

Int J Mol Sci. 2019 Mar 25;20(6). pii: E1482. doi: 10.3390/ijms20061482. Review.

17.

Toward understanding the impact of artificial intelligence on labor.

Frank MR, Autor D, Bessen JE, Brynjolfsson E, Cebrian M, Deming DJ, Feldman M, Groh M, Lobo J, Moro E, Wang D, Youn H, Rahwan I.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6531-6539. doi: 10.1073/pnas.1900949116. Epub 2019 Mar 25.

18.

Emamectin benzoate in tilapia: Alternative method for drug incorporation into feed and associated residual depletion study.

Neto PF, da Silva AFB, Moro EB, Pilarski F, de Freitas O, Mooney MH, Paschoal JAR.

Food Res Int. 2019 May;119:524-529. doi: 10.1016/j.foodres.2019.01.033. Epub 2019 Jan 17.

PMID:
30884685
19.

Battery longevity of neurostimulators in Parkinson disease: A historic cohort study.

Sette AL, Seigneuret E, Reymond F, Chabardes S, Castrioto A, Boussat B, Moro E, François P, Fraix V.

Brain Stimul. 2019 Jul - Aug;12(4):851-857. doi: 10.1016/j.brs.2019.02.006. Epub 2019 Feb 25.

PMID:
30842036
20.

Asymmetric STN DBS for FOG in Parkinson's disease: A pilot trial.

Meoni S, Debȗ B, Pelissier P, Scelzo E, Castrioto A, Seigneuret E, Chabardes S, Fraix V, Moro E.

Parkinsonism Relat Disord. 2019 Jun;63:94-99. doi: 10.1016/j.parkreldis.2019.02.032. Epub 2019 Feb 25.

PMID:
30826266
21.

Cervical dystonia in a case of longstanding secondary progressive multiple sclerosis.

Cavallieri F, Godeiro C, Lino JC Jr, Moro E.

Rev Neurol (Paris). 2019 Apr;175(4):269-271. doi: 10.1016/j.neurol.2018.05.005. Epub 2019 Jan 3. No abstract available.

PMID:
30612702
22.

Differential Expression of HOX Genes in Mesenchymal Stem Cells from Osteoarthritic Patients Is Independent of Their Promoter Methylation.

Mucientes A, Herranz E, Moro E, Lajas C, Candelas G, Fernández-Gutiérrez B, Lamas JR.

Cells. 2018 Dec 5;7(12). pii: E244. doi: 10.3390/cells7120244.

23.

Surgical, Clinical, and Functional Outcomes in Patients with Rectosigmoid Endometriosis in the Gray Zone: 13-Year Long-Term Follow-up.

Mabrouk M, Raimondo D, Altieri M, Arena A, Del Forno S, Moro E, Mattioli G, Iodice R, Seracchioli R.

J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1110-1116. doi: 10.1016/j.jmig.2018.08.031. Epub 2018 Nov 9.

PMID:
30414996
24.

The Golgi 'casein kinase' Fam20C is a genuine 'phosvitin kinase' and phosphorylates polyserine stretches devoid of the canonical consensus.

Cozza G, Moro E, Black M, Marin O, Salvi M, Venerando A, Tagliabracci VS, Pinna LA.

FEBS J. 2018 Dec;285(24):4674-4683. doi: 10.1111/febs.14689. Epub 2018 Nov 20.

25.

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P.

Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.

26.

The effect of methadone on postoperative quality of recovery in patients undergoing laparoscopic cholecystectomy: A prospective, randomized, double blinded, controlled clinical trial.

Moro ET, Lambert MF, Pereira AL, Artioli T, Graicer G, Bevilacqua J, Bloomstone J.

J Clin Anesth. 2019 Mar;53:64-69. doi: 10.1016/j.jclinane.2018.09.031. Epub 2018 Oct 13.

PMID:
30326380
27.

Sex- and age-related differences of metabolic parameters in impaired glucose metabolism and type 2 diabetes compared to normal glucose tolerance.

Tura A, Pacini G, Moro E, Vrbíková J, Bendlová B, Kautzky-Willer A.

Diabetes Res Clin Pract. 2018 Dec;146:67-75. doi: 10.1016/j.diabres.2018.09.019. Epub 2018 Oct 1.

PMID:
30287229
28.

Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease.

Martínez-Fernández R, Kibleur A, Chabardès S, Fraix V, Castrioto A, Lhommée E, Moro E, Lescoules L, Pelissier P, David O, Krack P.

Hum Brain Mapp. 2018 Dec;39(12):5014-5027. doi: 10.1002/hbm.24341. Epub 2018 Sep 26.

PMID:
30259598
29.

Parametrial Endometriosis: The Occult Condition that Makes the Hard Harder.

Mabrouk M, Raimondo D, Arena A, Iodice R, Altieri M, Sutherland N, Salucci P, Moro E, Seracchioli R.

J Minim Invasive Gynecol. 2019 Jul - Aug;26(5):871-876. doi: 10.1016/j.jmig.2018.08.022. Epub 2018 Aug 31.

PMID:
30176361
30.

Identification and Quantification of Thujone in a Case of Poisoning Due to Repeated Ingestion of an Infusion of Artemisia Vulgaris L.

Di Lorenzo C, Ferretti F, Moro E, Ceschi A, Colombo F, Frigerio G, Lüde S, Restani P.

J Food Sci. 2018 Aug;83(8):2257-2264. doi: 10.1111/1750-3841.14273. Epub 2018 Jul 25.

31.

Non-motor effects of deep brain stimulation in dystonia: A systematic review.

Eggink H, Szlufik S, Coenen MA, van Egmond ME, Moro E, Tijssen MAJ.

Parkinsonism Relat Disord. 2018 Oct;55:26-44. doi: 10.1016/j.parkreldis.2018.06.024. Epub 2018 Jun 20. Review.

PMID:
29945825
32.

What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?

Thevathasan W, Moro E.

Neurobiol Dis. 2019 Aug;128:67-74. doi: 10.1016/j.nbd.2018.06.014. Epub 2018 Jun 19. Review.

PMID:
29933055
33.

Analyzing gender inequality through large-scale Facebook advertising data.

Garcia D, Mitike Kassa Y, Cuevas A, Cebrian M, Moro E, Rahwan I, Cuevas R.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):6958-6963. doi: 10.1073/pnas.1717781115. Epub 2018 Jun 19.

34.

FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII).

Bellesso S, Salvalaio M, Lualdi S, Tognon E, Costa R, Braghetta P, Giraudo C, Stramare R, Rigon L, Filocamo M, Tomanin R, Moro E.

Hum Mol Genet. 2018 Jul 1;27(13):2407. doi: 10.1093/hmg/ddy208. No abstract available.

PMID:
29917101
35.

Surgical treatment of dystonia.

Cury RG, Kalia SK, Shah BB, Jimenez-Shahed J, Prashanth LK, Moro E.

Expert Rev Neurother. 2018 Jun;18(6):477-492. doi: 10.1080/14737175.2018.1478288. Epub 2018 May 28. Review.

PMID:
29781334
36.

The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation.

Fiorenza MT, Moro E, Erickson RP.

Hum Mol Genet. 2018 Aug 1;27(R2):R119-R129. doi: 10.1093/hmg/ddy155. Review.

PMID:
29718288
37.

Weather impacts expressed sentiment.

Baylis P, Obradovich N, Kryvasheyeu Y, Chen H, Coviello L, Moro E, Cebrian M, Fowler JH.

PLoS One. 2018 Apr 25;13(4):e0195750. doi: 10.1371/journal.pone.0195750. eCollection 2018.

38.

Functional movement disorders arising after successful deep brain stimulation.

Breen DP, Rohani M, Moro E, Mayberg HS, Zurowski M, Lozano AM, Fasano A.

Neurology. 2018 May 15;90(20):931-932. doi: 10.1212/WNL.0000000000005530. Epub 2018 Apr 13. No abstract available.

PMID:
29653985
39.

FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII).

Bellesso S, Salvalaio M, Lualdi S, Tognon E, Costa R, Braghetta P, Giraudo C, Stramare R, Rigon L, Filocamo M, Tomanin R, Moro E.

Hum Mol Genet. 2018 Jul 1;27(13):2262-2275. doi: 10.1093/hmg/ddy131. Erratum in: Hum Mol Genet. 2018 Jul 1;27(13):2407.

PMID:
29648648
40.

Managing Gait, Balance, and Posture in Parkinson's Disease.

Debû B, De Oliveira Godeiro C, Lino JC, Moro E.

Curr Neurol Neurosci Rep. 2018 Apr 6;18(5):23. doi: 10.1007/s11910-018-0828-4. Review.

PMID:
29623455
41.

Medical and surgical management of advanced Parkinson's disease.

Antonini A, Moro E, Godeiro C, Reichmann H.

Mov Disord. 2018 Jul;33(6):900-908. doi: 10.1002/mds.27340. Epub 2018 Mar 23. Review.

PMID:
29570862
42.

Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.

Arlotti M, Marceglia S, Foffani G, Volkmann J, Lozano AM, Moro E, Cogiamanian F, Prenassi M, Bocci T, Cortese F, Rampini P, Barbieri S, Priori A.

Neurology. 2018 Mar 13;90(11):e971-e976. doi: 10.1212/WNL.0000000000005121. Epub 2018 Feb 14.

43.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Abbes M, Lhommée E, Thobois S, Klinger H, Schmitt E, Bichon A, Castrioto A, Xie J, Fraix V, Kistner A, Pélissier P, Seigneuret É, Chabardès S, Mertens P, Broussolle E, Moro E, Krack P.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):836-843. doi: 10.1136/jnnp-2017-316373. Epub 2018 Feb 7.

PMID:
29436490
44.

Pallidal deep brain stimulation modulates cortical excitability and plasticity.

Ni Z, Kim SJ, Phielipp N, Ghosh S, Udupa K, Gunraj CA, Saha U, Hodaie M, Kalia SK, Lozano AM, Lee DJ, Moro E, Fasano A, Hallett M, Lang AE, Chen R.

Ann Neurol. 2018 Feb;83(2):352-362. doi: 10.1002/ana.25156.

PMID:
29369401
45.

Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry.

Martinez-Ramirez D, Jimenez-Shahed J, Leckman JF, Porta M, Servello D, Meng FG, Kuhn J, Huys D, Baldermann JC, Foltynie T, Hariz MI, Joyce EM, Zrinzo L, Kefalopoulou Z, Silburn P, Coyne T, Mogilner AY, Pourfar MH, Khandhar SM, Auyeung M, Ostrem JL, Visser-Vandewalle V, Welter ML, Mallet L, Karachi C, Houeto JL, Klassen BT, Ackermans L, Kaido T, Temel Y, Gross RE, Walker HC, Lozano AM, Walter BL, Mari Z, Anderson WS, Changizi BK, Moro E, Zauber SE, Schrock LE, Zhang JG, Hu W, Rizer K, Monari EH, Foote KD, Malaty IA, Deeb W, Gunduz A, Okun MS.

JAMA Neurol. 2018 Mar 1;75(3):353-359. doi: 10.1001/jamaneurol.2017.4317. Erratum in: JAMA Neurol. 2018 Mar;75(3):384.

46.

Adaptive Deep Brain Stimulation (aDBS) for Tourette Syndrome.

Marceglia S, Rosa M, Servello D, Porta M, Barbieri S, Moro E, Priori A.

Brain Sci. 2017 Dec 23;8(1). pii: E4. doi: 10.3390/brainsci8010004.

47.

Changes in hyaluronan deposition in the rat myenteric plexus after experimentally-induced colitis.

Filpa V, Bistoletti M, Caon I, Moro E, Grimaldi A, Moretto P, Baj A, Giron MC, Karousou E, Viola M, Crema F, Frigo G, Passi A, Giaroni C, Vigetti D.

Sci Rep. 2017 Dec 15;7(1):17644. doi: 10.1038/s41598-017-18020-7.

48.

Reversing dopaminergic sensitization.

Castrioto A, Carnicella S, Fraix V, Chabardes S, Moro E, Krack P.

Mov Disord. 2017 Dec;32(12):1679-1683. doi: 10.1002/mds.27213. Epub 2017 Nov 18. Review. No abstract available.

PMID:
29150871
49.

Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study.

Jiang L, Poon WS, Moro E, Xian W, Yang C, Zhu XL, Gu J, Cai X, Liu J, Mok V, Liu Y, Xu S, Guo Q, Chen W, Chen L.

BMJ Open. 2017 Nov 16;7(11):e018610. doi: 10.1136/bmjopen-2017-018610.

50.

Celebrating thirty years of deep brain stimulation in movement disorders patients: A successful marriage between neurologists and neurosurgeons.

Cury RG, Fraix V, Moro E.

Parkinsonism Relat Disord. 2018 Jan;46:98-99. doi: 10.1016/j.parkreldis.2017.11.007. Epub 2017 Nov 11. No abstract available.

PMID:
29150220

Supplemental Content

Support Center